AXIS-Y Launches Triple PDRN Barrier Boost Serum, Its Most Advanced Recovery Formula Yet
SEOUL, South Korea, Aug. 21, 2026 /PRNewswire/ -- AXIS-Y, the vegan, climate-inspired Korean skincare brand, today announced the launch of its Triple PDRN Barrier Boost Serum, a recovery-focused formula designed for stressed skin barriers. AXIS-Y's...
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy
NANJING, China, Aug. 21, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has...
STARTRADER Launches XAUUSD247, Extending Gold CFD Access Across the Full Week
The new instrument provides XAUUSD247 quotes during weekends and overnight hours, subject to scheduled maintenance windows. PORT LOUIS, Mauritius, Aug. 21, 2026 /PRNewswire/ -- STARTRADER today announced the launch of XAUUSD247, a gold CFD that...
Colgate-Palmolive elevates Prabha Narasimhan to EVP - Marketing, Asia-Pacific
MUMBAI, India, Aug. 21, 2026 /PRNewswire/ -- Prabha Narasimhan, Managing Director and Chief Executive Officer of Colgate-Palmolive (India) Limited has been elevated to the role of Executive Vice President – Marketing, Asia-Pacific Division,...
Plotio Strengthens Internal Risk Governance Through Employee Training and Talent Development
TAIPEI, Aug. 21, 2026 /PRNewswire/ -- As artificial intelligence (AI) continues to reshape the way the financial industry operates, Plotio, like a growing number of institutions, recognises that technology is unlikely to fully replace human...
giga! Equips All Eligible MILK Fund Scholars with One-year gigaFLEX+ Plan
One-year gigaFLEX+ sponsorship supports over 2,000 MILK fund scholars aged 17 to 25 with the digital tools to learn, create and thrive in an AI-enabled future SINGAPORE, Aug. 21, 2026 /PRNewswire/ -- giga! has partnered with the MILK (Mainly I Love...
Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026
SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- Dizal (SSE: 688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that the latest clinical data on its novel...
ATLANT 3D Launches NANOFABRICATOR® PRO: The World's First and Only Physical Platform for AI-Driven Materials Discovery
COPENHAGEN, Denmark, Aug. 17, 2026 /PRNewswire/ -- ATLANT 3D today announced the launch of NANOFABRICATOR® PRO, the world's first and only physical platform for AI-driven materials discovery. The platform connects AI-driven materials discovery with...